Хайлтын үр дүнгүүд - Francesco Gaudio

  • 4-н 1 - 4 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    Inflammatory Cells in Diffuse Large B Cell Lymphoma

    Inflammatory Cells in Diffuse Large B Cell Lymphoma -н Roberto Tamma, Girolamo Ranieri, Giuseppe Ingravallo, Tiziana Annese, Angela Oranger, Francesco Gaudio, Pellegrino Musto, Giorgina Specchia, Doménico Ribatti

    Хэвлэсэн 2020
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Exploring the Role of Epithelial–Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review

    Exploring the Role of Epithelial–Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review -н Raana Kanwal, Jessica Elisabetta Esposito, Bilal Jawed, Syed Khuram Zakir, Riccardo Pulcini, R Martinotti, Matteo Botteghi, Francesco Gaudio, Stefano Martinotti, Elena Toniato

    Хэвлэсэн 2025
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma

    Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma -н Giuseppe Visani, Pietro Maria Stefani, Saveria Capria, Lara Malerba, Piero Galieni, Francesco Gaudio, Giorgina Specchia, Giovanna Meloni, Filíppo Gherlinzoni, Roberta Gonella, Marco Gobbi, Armando Santoro, Felicetto Ferrara, Marco Rocchi, Enrique M. Ocio, Marı́a Dolores Caballero, Federica Loscocco, Alessandro Isidori

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Carta
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

    BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients -н Giuseppe Visani, Lara Malerba, Pietro Maria Stefani, Saveria Capria, Piero Galieni, Francesco Gaudio, Giorgina Specchia, Giovanna Meloni, Filíppo Gherlinzoni, Claudio Giardini, Sadia Falcioni, Francesca Cuberli, Marco Gobbi, Barbara Sarina, Armando Santoro, Felicetto Ferrara, Marco Rocchi, Enrique M. Ocio, Marı́a Dolores Caballero, Alessandro Isidori

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: